Ipamorelin

Ipamorelin

Ipamorelin is a synthetic pentapeptide ghrelin-receptor (GHS-R1a) agonist studied as a research material. It is a selective growth-hormone secretagogue of the GHRP class, not a GHRH-receptor ligand. This listing is for laboratory research use only. It is not a drug, food, cosmetic, or dietary supplement, and it is not approved for human or veterinary use.

Research Context

Ipamorelin appears in the scientific literature from the late 1990s as a selective GH secretagogue examined with limited effect on cortisol and ACTH in experimental comparisons with earlier GHRP ligands. This page does not describe administration, dosing, or personal use.

Research Overview

Published work has examined ipamorelin in controlled experimental systems of pituitary GH release via ghrelin-receptor signaling. Findings from those models are not established as safe or effective for people or animals, and nothing here is medical advice.

Key Research Focus Areas

• Ghrelin-receptor (GHS-R1a) agonist identity
• Selective GH-secretion models versus earlier GHRP ligands
• Pituitary and neuroendocrine signaling assays
• Comparative pharmacology among growth-hormone secretagogues

Important Disclaimer

For research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, or prevent any disease. Not medical advice. Handle only in a qualified research setting and in compliance with applicable law.